Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 70518-4165

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 70518-4165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine Hydrochlorothi 1)

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine Hydrochlorothi 1)
Chemical structure of olmesartan medoxomil, an active ingredient in the combination tablet containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide.*
FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine Hydrochlorothi 2)

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine Hydrochlorothi 2)
Chemical structure diagram showing the active ingredient olmesartan medoxomil and associated components as represented in the product olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide tablets.*
FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine Hydrochlorothi 3)

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine Hydrochlorothi 3)
Chemical structure diagram of the active ingredient olmesartan medoxomil, showing its ring system with attached functional groups including sulfonamide and chlorine atoms.*
FDA Label Image

Fig-1 (Olmesartan Medoxomil Amlodipine Hydrochlorothi 4)

Fig-1 (Olmesartan Medoxomil Amlodipine Hydrochlorothi 4)
A line chart depicting mean ambulatory diastolic blood pressure (mmHg) over 24 hours post dose. The x-axis shows hours from 0 to 24, and the y-axis measures diastolic BP from 55 to 100 mmHg. Five lines represent different treatment or baseline groups, with a legend showing Baseline, AML10/HCTZ25, OM40/AML10, OM40/AML10/HCTZ25, and OM40/HCTZ25.*
FDA Label Image

Fig-2 (Olmesartan Medoxomil Amlodipine Hydrochlorothi 5)

Fig-2 (Olmesartan Medoxomil Amlodipine Hydrochlorothi 5)
A line graph showing the mean ambulatory systolic blood pressure (mmHg) over 24 hours post dose for different drug regimens. The x-axis represents hours post dose from 0 to 24, and the y-axis shows blood pressure from 105 to 160 mmHg. Five lines with distinct markers compare baseline, OL40/AML10, OL40/HCTZ25, AML10/HCTZ25, and OL40/AML10/HCTZ25 combinations.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label of olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 40 mg / 5 mg / 25 mg film-coated tablets by RemedyRepack Inc. The package contains 30 tablets for oral use. The label includes dosing strength, quantity, NDC 70518-4165-00, and manufacturer information with storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.